The stock’s shares went for about $868 in early June, up more than 93 percent over the last year. Bottom line Eli Lilly’s stock price is riding a wave of optimism and strong earnings.

Eli Lilly is serving a market that may reach $100 billion. Eli Lilly (LLY 0.16%) stock has soared 90% over the past year, a huge gain for a pharmaceutical company.

Eli Lilly's stock isn't cheap The company's stock trades at a hefty 39 times forward earnings. That's very high for a pharma company and more than twice its main GLP-1 competitor, Novo Nordisk.

Eli Lilly (NYSE: LLY) stock has soared 90% over the past year, a huge gain for a pharmaceutical company. These stocks generally are known for steady increases over time instead of big movements ...

Through an analysis of Eli Lilly, we can infer the following trends: At 86.87, the stock's Price to Earnings ratio significantly exceeds the industry average by 3.52x, suggesting a premium ...

However, when looking at the fundamental performance of these two, I don’t see many reasons for the stock outperformance of Eli Lilly. At best, we can call it a head-to-head race.

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly and Company (NYSE:LLY) is one of the Stocks With Huge Catalysts on the Horizon. On July 21, Eli Lilly and Company ...

Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance Eli Lilly sees FY24 EPS $12.20-$12.70, consensus $12.43 Eli Lilly reports Q4 EPS $2.49, consensus $2.19 ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.